Abstract | BACKGROUND: Children with cancer frequently have associated cachexia and malnutrition. Failure to thrive affects nearly 40% of oncology patients with advanced or progressive disease. Malnutrition can erode quality of life and adversely impact disease prognosis. Appetite stimulation and increased food intake is 1 approach to combat cancer-related cachexia. MATERIALS AND METHODS:
Cyproheptadine hydrochloride (CH), an appetite stimulant, was administered to children with cancer-associated cachexia to prevent further weight loss. All participants started CH and were evaluated for response after 4 weeks. Efficacy of megestrol acetate (MA) was evaluated in patients who did not respond to CH. Medical evaluation, weight measurements, prealbumin, and serum leptin levels were preformed at follow-up visits. RESULTS: Seventy patients were enrolled. Of the 66 evaluable patients, 50 demonstrated a response to CH (average weight gain 2.6 kg and mean weight-for-age z-score change of 0.35, P=0.001). Seven of the 16 nonresponders received MA. Six patients completed 4 weeks of MA, 5 responded (average weight gain of 2.5 kg). The most commonly reported side effect of CH was drowsiness. One patient on MA developed low cortisol levels and hyperlipidemia. CONCLUSIONS:
|
Authors | Marisa Couluris, Jennifer L R Mayer, David R Freyer, Eric Sandler, Ping Xu, Jeffrey P Krischer |
Journal | Journal of pediatric hematology/oncology
(J Pediatr Hematol Oncol)
Vol. 30
Issue 11
Pg. 791-7
(Nov 2008)
ISSN: 1536-3678 [Electronic] United States |
PMID | 18989154
(Publication Type: Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Appetite Stimulants
- Gastrointestinal Agents
- Cyproheptadine
- Megestrol Acetate
|
Topics |
- Adolescent
- Adult
- Appetite Stimulants
(therapeutic use)
- Cachexia
(drug therapy, etiology)
- Child
- Child, Preschool
- Cyproheptadine
(therapeutic use)
- Female
- Gastrointestinal Agents
(therapeutic use)
- Humans
- Male
- Megestrol Acetate
(therapeutic use)
- Neoplasm Recurrence, Local
(diagnosis, drug therapy)
- Neoplasms
(complications, pathology)
- Prognosis
- Quality of Life
- Weight Gain
(drug effects)
|